Relmada Therapeutics (RLMD) Change in Receivables (2016 - 2023)
Relmada Therapeutics (RLMD) reported Change in Receivables of -$512432.0 for Q1 2023, down 6906.11% on a QoQ basis from $7529.0 in Q1 2020.
Relmada Therapeutics (RLMD) has 6 years of Change in Receivables data on file, last reported at -$512432.0 in Q1 2023.
- Quarterly Change in Receivables changed N/A year-over-year to -$512432.0 in Q1 2023, while the trailing twelve-month figure through Dec 2023 was -$512432.0 (changed N/A YoY) and the FY2023 annual result came in at -$512432.0, down 200.0% from the prior year.
- Change in Receivables slipped to -$512432.0 in Q1 2023 per RLMD's latest filing, from $7529.0 in the prior quarter.
- Across five years, Change in Receivables topped out at $176980.0 in Q2 2019 and bottomed at -$512432.0 in Q1 2023.
- The 3-year median for Change in Receivables is -$176980.0 (2019), against an average of -$136376.6.
- Peak annual rise in Change in Receivables reached 2223.49% in 2019, while the deepest fall reached 2223.49% in 2019.
- Tracing RLMD's Change in Receivables over 3 years: stood at -$176980.0 in 2019, then surged by 104.25% to $7529.0 in 2020, then plunged by 6906.11% to -$512432.0 in 2023.
- Per Business Quant, the three latest RLMD Change in Receivables figures stand at -$512432.0 (Q1 2023), $7529.0 (Q1 2020), and -$176980.0 (Q4 2019).
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Change in Receivables (Qtr) |
|---|---|---|---|---|---|
| 1 | Quantum Biopharma | 961,148.99 Bn | 961,148.98 Bn | - | 208,524.00 |
| 2 | Alterity Therapeutics | 744,933.29 Bn | 744,933.26 Bn | - | - |
| 3 | Legend Biotech | 2,540.00 Bn | 2,539.71 Bn | 242.10 Mn | - |
| 4 | Nanobiotix | 2,199.85 Bn | 2,199.78 Bn | - | - |
| 5 | Akari Therapeutics | 1,635.88 Bn | 1,635.88 Bn | - | - |
| 6 | Vertex Pharmaceuticals | 111.32 Bn | 104.07 Bn | 2.59 Bn | -39.80 Mn |
| 7 | Evaxion A | 62.56 Bn | 62.54 Bn | - | - |
| 8 | Regeneron Pharmaceuticals | 62.55 Bn | 53.79 Bn | 3.31 Bn | -1.20 Mn |
| 9 | Alnylam Pharmaceuticals | 39.57 Bn | 36.56 Bn | 959.66 Mn | 110.42 Mn |
| 10 | Relmada Therapeutics | 595.35 Mn | 595.35 Mn | - | - |
Historic Data
Download Data| Date | Value |
|---|---|
| Mar 31, 2023 | -512,432.00 |
| Mar 31, 2023 | -512,432.00 |
| Mar 31, 2020 | 7,529.00 |
| Mar 31, 2020 | 7,529.00 |
| Dec 31, 2019 | -176,980.00 |
| Dec 31, 2019 | -176,980.00 |
| Sep 30, 2019 | -176,980.00 |
| Sep 30, 2019 | -176,980.00 |
| Jun 30, 2019 | 176,980.00 |
| Jun 30, 2019 | 176,980.00 |
| Sep 30, 2018 | -7,617.00 |
| Sep 30, 2018 | -7,617.00 |
| Jun 30, 2018 | 7,617.00 |
| Jun 30, 2018 | 7,617.00 |
| Dec 31, 2017 | -150,617.00 |
| Dec 31, 2017 | -150,617.00 |
| Sep 30, 2017 | -81,980.00 |
| Sep 30, 2017 | -81,980.00 |
| Sep 30, 2016 | 2,350.00 |
| Sep 30, 2016 | 2,350.00 |